NCI Head Stepping Down

Harold Varmus, who has led the US National Cancer Institute since 2010, is leaving his appointment at the end of the month.

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Harold VarmusNCINational Cancer Institute (NCI) Director Harold Varmus is stepping down from his post at the end of this month, the agency announced yesterday (March 4). He has held the position since July 2010. Douglas Lowy, NCI’s deputy director, will become acting director of the agency beginning April 1.

“I take this step with a mixture of regret and anticipation. Regret, because I will miss this job and my working relationships with so many dedicated and talented people,” Varmus wrote in a March 4 letter to NCI staff. “Anticipation, because I look forward to new opportunities to pursue scientific work in the city, New York, that I continue to call home.”

In a March 3 letter to President Barack Obama, Varmus wrote: “The past five years have not been easy times financially for biomedical research, including cancer research, but they continue to be extraordinarily promising scientifically.”

“It has been our great fortune to have Harold at the helm of the NCI,” National Institutes of Health Director Francis Collins said in a statement. “His breadth ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies